INTEGRATED CORE STRATEGIES (US) LLC - 29 Sep 2025 SCHEDULE 13G Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
19,770,250 shares
Disclosed Ownership
1,028,053 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
01 Oct 2025, 16:15:17 UTC
Date of event
29 Sep 2025
Next filing
09 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.2% ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI) on 29 Sep 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI).
  • Disclosed ownership: 5.2%.
  • Date of event: 29 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 Oct 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.2% 1,026,054 0 1,026,054 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.2% 1,028,053 0 1,028,053 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.2% 1,028,053 0 1,028,053 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.2% 1,028,053 0 1,028,053 /s/ Israel A. Englander Israel A. Englander

Sponsored